Probably, I think so...I believe both of these outcomes have been very clear and positive in the pre-human trials, right?
Probably, I think so...I believe both of these outcomes have been very clear and positive in the pre-human trials, right?
It's nice to see that they are getting more money but it also seems that they are buying more time.
They made it clear when they announced the San Antonio trial that it was a safety trial. The measures they use for safety are the same ones they use for efficacy, though, so...As far as I understand, this is not the case with a Phase 1/2 study. A Phase 1 study is safety only, but a 1/2 is a combined study to skip ahead and get initial efficiency results as well.
It seems that as a group we oscillate between seeing Frequency Therapeutics as God's gift to the hearing impaired and seeing them as money-grubbers who are just stringing us along.It's nice to see that they are getting more money but it also seems that they are buying more time.
Not surprised...
It is going to be God's gift to the hearing impaired. I wouldn't call them money grubbers. They didn't invent the process of approving drugs, they are just playing a game that unfortunately for us must be played. It would have been really nice if they would have included tinnitus as a metric in this trial and already released the results but oh well.It seems that as a group we oscillate between seeing Frequency Therapeutics as God's gift to the hearing impaired and seeing them as money-grubbers who are just stringing us along.
Maybe the truth lies somewhere in between?
Possible, yes.Rookie question, but would it not be possible to find and contact one or some of the participants, and simply ask them about tinnitus?
Since they moved the results to the first half of 2019, is this effectively shifting the start of Phase II?
(I love you mods, btw.)
They take far more metrics than just what they announce for the study.As far as I understand, this is not the case with a Phase 1/2 study. A Phase 1 study is safety only, but a 1/2 is a combined study to skip ahead and get initial efficiency results as well.
Would the investor(s) of 42MUSD jump onto this after only seeing a safety profile from the ongoing trial? Maybe, but I think we a cash-injection like that, they've been shown more.
I'd second that... surely the speech must have had some new information?So did we ever find anything out about the conference they had on January 7th? It seems like the financing that they announced came out just before the conference started.
Good points. What I was trying to say is that the big news is that they got an external new investor who has seen all the data and after analysis decided to invest into Frequency Therapeutics.As far as I understand, this is not the case with a Phase 1/2 study. A Phase 1 study is safety only, but a 1/2 is a combined study to skip ahead and get initial efficiency results as well.
Would the investor(s) of 42MUSD jump onto this after only seeing a safety profile from the ongoing trial? Maybe, but I think we a cash-injection like that, they've been shown more.
Frequency Therapeutics must maximise profits and value from the technology as they have already raised some 90MUSD from external professional investors. Owners of these investors look to get max profits back as is common sense.It seems that as a group we oscillate between seeing Frequency Therapeutics as God's gift to the hearing impaired and seeing them as money-grubbers who are just stringing us along.
Maybe the truth lies somewhere in between?
I didn't screen with anyone else. I think they only screened one person a day. I thought about waiting outside in the bushes for the next person to come along but didn't.Possible, yes.
They have probably signed non-disclosure agreements with the trial agency though.
I forgot if @Deathtotinni mentioned anything about that. He made it all the way there so he may have some inside baseball on this topic.
I second this. Are we really going to have to wait until the summer before they release the results of the trial? I mean, come on! The trial ended in December. Why won't they release the results?Does anyone have any idea when the next study will be or how to find out when it is starting?
Although the trials finished in 12-2018 they still haven't published so we need to wait for them first and see what happened to those 24 people. By the way, if they will be successful there were exclusions in the trials:Does anyone have any idea when the next study will be or how to find out when it is starting?
Yea it is completely asinine to think that after this second trial that they wouldn't be looking at the audiograms that they are definitely giving the subjects to see if their hearing improves. As of they wouldn't be interested because "this is just a safety study".As far as I understand, this is not the case with a Phase 1/2 study. A Phase 1 study is safety only, but a 1/2 is a combined study to skip ahead and get initial efficiency results as well.
Would the investor(s) of 42MUSD jump onto this after only seeing a safety profile from the ongoing trial? Maybe, but I think we a cash-injection like that, they've been shown more.
The investigators literally said they are testing to see if there is improvement in hearing.People that are saying that they have no knowledge of efficacy at this point "because this is just a safety trial" need to sit this discussion out because they are clueless.
I have not read the protocol, but they may be using a hearing test as a safety measure in the sense they want to look for an adverse effect of the drug on hearing, ie. has hearing worsened as a result of drug use. How do the timepoints compare to the time it takes for hair cells to regenerate? TCThis is an efficacy study disguised as a safety study. They are mainly testing for efficiency from what I gathered. They are giving you the drug, keeping you overnight, testing hearing, bringing you back to test hearing, and then back again to test it again.